The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells

Bone Marrow Transplantation

Volumn 35, Issue 11, 2005, Pages 1049-1054

  McGregor, D K ^a   Keever Taylor, C A ^b   Bredeson, C ^b   Schur, B ^b   Vesole, D H ^b   Logan, B ^b   Chang, C C ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

Lymphoma; Quantitative PCR; Stem cell transplant

Indexed keywords

ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MINIMAL RESIDUAL DISEASE; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCREENING; SURVIVAL RATE;

ADULT; BONE MARROW CELLS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TIME FACTORS; TISSUE DONORS; TRANSLOCATION, GENETIC; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 20044389355     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704969     Document Type: Article

References (28)

1. Turner GE, Ross FM, Krajewski AS. Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reaction. Br J Haematol 1995; 89: 223-225.
2. Pappa VI, Wilkes S, Salam A et al. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment. Bone Marrow Transplant 1998; 22: 553-558.
3. Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol 2002; 160: 759-763.
4. Yasukawa M, Bando S, Dolken G et al. Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 2001; 98: 486-488.
5. Ladetto M, Drandi D, Compagno M et al. PCR-detectable nonneoplastic Bcl-2/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 2003; 21: 1398-1403.
6. Ji W, Qu GZ, Ye P et al. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay. Cancer Res 1995; 55: 2876-2882.
7. Summers KE, Goff LK, Wilson AG et al. Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 2001; 19: 420-424.
8. Tsimberidou AM, Jiang Y, Ford RJ et al. Quantitative realtime polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma. Leuk Lymphoma 2002; 43: 1589-1598.
9. Fuscoe JC, Setzer RW, Collard DD, Moore MM. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens. Carcinogenesis 1996; 17: 1013-1020.
10. Liu Y, Hernandez AM, Shibata D, Cortopassi GA. BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 1994; 91: 8910-8914.
11. Dolken G, Illerhaus G, Hirt C, Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 1996; 14: 1333-1344.
12. Finke J. The role of stem cell transplantation in the treatment of follicular lymphoma. Semin Cancer Biol 2003; 13: 233-239.
13. van Besien K, Loberiza Jr FR, Bajorunaite R et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood 2003; 102: 3521-3529.
14. Juckett M, Rowlings P, Hessner M et al. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transplant 1998; 21: 893-899.
15. Stein RS, Greer JP, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227-233.
16. Chang CC, Bredeson C, Juckett M et al. Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course. Bone Marrow Transplant 2003; 32: 287-291.
17. Rosenblum MD, Drobyski WR, Keever-Taylor C, Chang CC. Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection posttransplant. Bone Marrow Transplant 2003; 31: 947-949.
18. Dolken L, Schuler F, Dolken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques 1998; 25: 1058-1064.
19. Hirt C, Dolken G. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant 2000; 25: 419-426.
20. Ladetto M, Sametti S, Donovan JW et al. A validated realtime quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. Exp Hematol 2001; 29: 183-193.
21. Mandigers CM, Meijerink JP, Mensink EJ et al. Lack of correlation between numbers of circulating t(14;18)-positive cells and response to first-line treatment in follicular lymphoma. Blood 2001; 98: 940-944.
22. Keever-Taylor CA, Craig A, Molter M et al. Complement-mediated T-cell depletion of bone marrow: comparison of T10B9.1A-31 and Muromonab-Orthoclone OKT3. Cytotherapy 2001; 3: 467-481.
23. Viardot A, Barth TF, Moller P et al. Cytogenetic evolution of follicular lymphoma. Semin Cancer Biol 2003; 13: 183-190.
24. Caporaso N, Marti GE, Goldin L. Perspectives on familial chronic lymphocytic leukemia: genes and the environment. Semin Hematol 2004; 41: 201-206.
25. Mandigers CM, Meijerink JP, Raemaekers JM et al. Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18). Lancet 1998; 352: 1522-1523.
26. Sarris AH, Jiang Y, Tsimberidou AM et al. Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone. Semin Oncol 2002; 29 (1 Suppl. 2): 48-55.
27. Summers KE, Davies AJ, Matthews J et al. The relative role of peripheral blood and bone marrow for monitoring molecular evidence of disease in follicular lymphoma by quantitative real-time polymerase chain reaction. Br J Haematol 2002; 118: 563-566.
28. Jenner MJ, Summers KE, Norton AJ et al. JH probe real-time quantitative polymerase chain reaction assay for Bcl-2/IgH rearrangements. Br J Haematol 2002; 118: 550-558.